 Castle Biosciences NASDAQ:CSTL Director Daniel Bradbury sold 3,750 shares of the stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of 43.18, for a total value of 161,925.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC ... 